{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:58:15Z","timestamp":1792807095617,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004299","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T00:00:00Z","timestamp":1276646400000}}],"reference-count":149,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004299.pub2","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T15:51:07Z","timestamp":1276617067000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Interventions for cellulitis and erysipelas"],"prefix":"10.1002","volume":"2020","author":[{"given":"Sally A","family":"Kilburn","sequence":"additional","affiliation":[{"name":"School of Health Sciences and Social Work; University of Portsmouth; Portsmouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Featherstone","sequence":"additional","affiliation":[{"name":"Queen Alexandra Hospital, University of Portsmouth; Portsmouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernie","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Mathematics; University of Portsmouth; Portsmouth, Hampshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Brindle","sequence":"additional","affiliation":[{"name":"Department of Pathology; Portsmouth Hospitals NHS Trust; Portsmouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,16]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/00365549709011834","article-title":"Antibiotic and prednisolone therapy of erysipelas: A randomized, double blind, placebo-controlled study","volume":"29","author":"Bergkvist","year":"1997","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2133.1992.tb08048.x","article-title":"Roxithromycin versus penicillin in the treatment of erysipelas in adults: A comparative study","volume":"127","author":"Bernard","year":"1992","journal-title":"British Journal of Dermatology"},{"issue":"7369","key":"10.1002\/14651858.CD004299.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/bmj.325.7369.864","article-title":"Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: Randomised, non-inferiority, open trial","volume":"325","author":"Bernard","year":"2002","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD004299.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0149-2918(02)80024-8","article-title":"Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections","volume":"24","author":"Bucko","year":"2002","journal-title":"Clinical Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD004299.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0149-2918(02)80024-8","article-title":"Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections","volume":"24","author":"Bucko","year":"2002","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0006|cit6","first-page":"139","article-title":"Ampicillin\/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology","volume":"12","author":"Chan","year":"1995","journal-title":"Advances in Therapy"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/030006059101900602","article-title":"Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group","volume":"19","author":"Daniel","year":"1991","journal-title":"Journal of International Medical Research"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/030006059101900602","article-title":"Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group","volume":"19","author":"Daniel","year":"1991","journal-title":"Journal of International Medical Research"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0009|cit9","first-page":"649","article-title":"Efficacy of two dosage schedules of cephalexin in dermatologic infections","volume":"12","author":"DiMattia","year":"1981","journal-title":"Journal of Family Practice"},{"issue":"3","key":"10.1002\/14651858.CD004299.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/sur.2005.6.269","article-title":"Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: Results of a multicenter, randomized, double blind comparative study","volume":"6","author":"Fabian","year":"2005","journal-title":"Surgical Infections"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijantimicag.2005.07.017","article-title":"Sequential intravenous\/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection","volume":"26","author":"Giordano","year":"2005","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"11","key":"10.1002\/14651858.CD004299.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1086\/340056","article-title":"Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults","volume":"34","author":"Grayson","year":"2002","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0013|cit13","first-page":"A13","article-title":"Once-daily IV cefazolin 2g plus oral probenecid 1g is equivalent to once-daily IV ceftriaxone 1g plus oral placebo for the hospital-in-the-home treatment of cellulitis","volume":"31","author":"Grayson","year":"2001","journal-title":"Internal Medicine Journal"},{"issue":"15","key":"10.1002\/14651858.CD004299.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis","volume":"164","author":"Hepburn","year":"2004","journal-title":"Archives of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0015|cit15","first-page":"214","article-title":"Multicenter comparison of cefonicid and cefazolin in hospitalized patients with skin and soft tissue infections","volume":"2","author":"Iannini","year":"1985","journal-title":"Advances in Therapy"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.12968\/jowc.2007.16.4.27026","article-title":"Can cycloidal vibration plus standard treatment reduce lower limb cellulitis treatment times?","volume":"16","author":"Johnson","year":"2007","journal-title":"Journal of Wound Care"},{"issue":"10","key":"10.1002\/14651858.CD004299.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/BF01975848","article-title":"Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections","volume":"10","author":"Kiani","year":"1991","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/emj.2004.019869","article-title":"Flucloxacillin alone or combined with benzylpenicillin to treat lower limb cellulitis: A randomised controlled trial","volume":"22","author":"Leman","year":"2005","journal-title":"Emergency Medicine Journal"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0002-9343(85)90144-5","article-title":"Ticarcillin plus calvulanic acid versus moxalactam in the treatment of skin and soft tissue infections","volume":"79 Suppl 2","author":"Rao","year":"1985","journal-title":"The American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004299.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF03259192","article-title":"Ampicillin\/sulbactam compared with cefazolin or cefoxitin for the treatment of skin and skin structure infections","volume":"2","author":"Sachs","year":"1990","journal-title":"Drug Investigation"},{"issue":"6A","key":"10.1002\/14651858.CD004299.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"90S","DOI":"10.1016\/S0002-9343(96)00111-8","article-title":"Current and future management of serious skin and skin-structure infections","volume":"100","author":"Schwartz","year":"1996","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0149-2918(98)80088-X","article-title":"Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group","volume":"20","author":"Tack","year":"1998","journal-title":"Clinical Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD004299.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1128\/AAC.45.8.2358-2362.2001","article-title":"Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: Double blind, multicenter, randomized study","volume":"45","author":"Tarshis","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00044011-199612050-00001","article-title":"A randomised comparative study of once-daily ceftriaxone and 6-hourly flucloxacillin in the treatment of moderate to severe cellulitis. Clinical efficacy, safety and pharmacoeconomic implications","volume":"12","author":"Vinen","year":"1996","journal-title":"Clinical Drug Investigation"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/AAC.49.6.2260-2266.2005","article-title":"Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections","volume":"49","author":"Weigelt","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1468-3083.2004.00938.x","article-title":"Intramuscular bipenicillin vs. intravenous penicillin in the treatment of erysipelas in adults: Randomized controlled study","volume":"18","author":"Zeglaoui","year":"2004","journal-title":"Journal of the European Academy of Dermatology and Venereology (JEADV)"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/20.suppl_B.153","article-title":"Roxithromycin in skin and soft tissue infections","volume":"20 Suppl B","author":"Agache","year":"1987","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/20.suppl_B.153","article-title":"Roxithromycin in skin and soft tissue infections","volume":"20 Suppl B","author":"Agache","year":"1987","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD004299.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0924-8579(92)90028-P","article-title":"Safety and efficacy of lomefloxacin and cefaclor in the treatment of skin and skin structure infections","volume":"2","author":"Amaya-Tapia","year":"1992","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/31.suppl_E.129","article-title":"Once-daily azithromycin in the treatment of adult skin and skin-structure infections","volume":"31 Suppl E","author":"Amaya-Tapia","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0031|cit31","first-page":"482","article-title":"Double-blind study of lomefloxacin vs. norfloxacin in the treatment of skin and soft tissue infections","volume":"37","author":"Arata","year":"1989","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD004299.pub2-BIB0032|cit32","first-page":"326","article-title":"A double-blind comparative study of S-1108 and cefaclor in skin and skin structure infections","volume":"42","author":"Arata","year":"1994","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0033|cit33","first-page":"740","article-title":"A multicenter, double-blind, double-placebo comparative study of SY 5555 versus cefaclor in the treatment of skin and skin structure infections","volume":"42","author":"Arata","year":"1994","journal-title":"Chemotherapy"},{"issue":"11","key":"10.1002\/14651858.CD004299.pub2-BIB0034|cit34","first-page":"1069","article-title":"A multicenter, double-blind, double placebo clinical trial of azithromycin versus cefaclor in the treatment of skin and skin structure infections","volume":"43","author":"Arata","year":"1995","journal-title":"Japanese Journal of Chemotherapy"},{"issue":"7","key":"10.1002\/14651858.CD004299.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00006454-199907000-00008","article-title":"Efficacy and safety of ampicillin\/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group","volume":"18","author":"Azimi","year":"1999","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0036|cit36","first-page":"70","article-title":"A comprehensive study of cefadroxil and cephalexin in the treatment of soft tissue infections","volume":"8 Suppl 1","author":"Ballantyne","year":"1980","journal-title":"Journal of International Medical Research"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0037|cit37","first-page":"487","article-title":"Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections","volume":"7","author":"Ballantyne","year":"1985","journal-title":"Clinical Therapeutics"},{"issue":"6A","key":"10.1002\/14651858.CD004299.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9343(84)80067-4","article-title":"Comparative evaluation of cefmenoxime versus cefoxitin in serious infections","volume":"77","author":"Bechard","year":"1984","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/003655498750003708","article-title":"Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: A 1-year follow-up","volume":"30","author":"Bergkvist","year":"1998","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0011-393X(98)85036-4","article-title":"Comparison of two regimens of oral clindamycin versus dicloxacillin in the treatment of mild-to-moderate skin and soft-tissue infections","volume":"59","author":"Blaszczyk-Kostanecka","year":"1998","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"issue":"4C","key":"10.1002\/14651858.CD004299.pub2-BIB0041|cit41","first-page":"63","article-title":"Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen","volume":"77","author":"Snow","year":"1984","journal-title":"American Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD004299.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1128\/AAC.49.11.4658-4666.2005","article-title":"Safety and efficacy of tigecycline in treatment of skin and skin structure infections: Results of a double-blind phase 3 comparison study with vancomycin-aztreonam","volume":"49","author":"Breedt","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0736-4679(96)00126-6","article-title":"Ceftriaxone versus cefazolin with probenecid for severe skin and soft tissue infections","volume":"14","author":"Brown","year":"1996","journal-title":"Journal of Emergency Medicine"},{"issue":"9","key":"10.1002\/14651858.CD004299.pub2-BIB0044|cit44","first-page":"559","article-title":"The efficacy of twice daily cephalexin","volume":"2","author":"Browning","year":"1981","journal-title":"Pharmatherapeutica"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/29.suppl_A.87","article-title":"Prospective randomized phase II study of intravenous cefpirome 1g or 2g bd in the treatment of hospitalized patients with different infections. Cefpirome Study Group","volume":"29 Suppl A","author":"Carbon","year":"1992","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0046|cit46","first-page":"79","article-title":"Overview of the efficacy of isepamicin in the adult core clinical trial programme","volume":"7 Suppl 2","author":"Carbon","year":"1995","journal-title":"Journal of Chemotherapy"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0047|cit47","first-page":"87","article-title":"Fusidic acid tablets in patients with skin and soft-tissue infection: A dose-finding study","volume":"5","author":"Carr","year":"1994","journal-title":"European Journal of Clinical Research"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jac\/16.5.643","article-title":"Sulbactam\/ampicillin: Effects on glucose metabolism in diabetics with soft tissue infection","volume":"16","author":"Chiodini","year":"1985","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"9","key":"10.1002\/14651858.CD004299.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00007611-199409000-00002","article-title":"Randomized comparison trial of teicoplanin i.v., teicoplanin i.m., and cefazolin therapy for skin and soft tissue infections caused by gram-positive bacteria","volume":"87","author":"Chirurgi","year":"1994","journal-title":"Southern Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD004299.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jac\/38.3.523","article-title":"Intravenous meropenem versus imipenem\/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group","volume":"38","author":"Colardyn","year":"1996","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD004299.pub2-BIB0051|cit51","first-page":"198","article-title":"Comparative double-blind evaluation of a new topical antibacterial agent, mupirocin, compared with placebo in the treatment of skin and soft tissue infections","volume":"5","author":"Colin","year":"1988","journal-title":"Pharmatherapeutica"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/AAC.34.4.654","article-title":"Randomized, double-blind trial of cefonicid and nafcillin in the treatment of skin and skin structure infections","volume":"34","author":"Daly","year":"1990","journal-title":"Antimicrobial Agents & Chemotherapy"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jac\/31.suppl_C.159","article-title":"Dirithromycin in the treatment of skin and skin structure infections","volume":"31 Suppl C","author":"Derriennic","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0054|cit54","first-page":"461","article-title":"Efficacy and safety of IV ciprofloxacin versus standard antimicrobial therapy in the treatment of selected tissue infections","volume":"11","author":"Echols","year":"1994","journal-title":"Infections in Medicine"},{"issue":"9","key":"10.1002\/14651858.CD004299.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/106002809102500901","article-title":"Intravenous or intramuscular teicoplanin once daily for skin and soft-tissue infections","volume":"25","author":"Edelstein","year":"1991","journal-title":"DICP : the annals of pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1128\/AAC.23.5.731","article-title":"Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings","volume":"23","author":"Eron","year":"1983","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"5A","key":"10.1002\/14651858.CD004299.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"164S","DOI":"10.1016\/0002-9343(89)90050-8","article-title":"Intravenous\/oral ciprofloxacin versus ceftazidime in the treatment of serious infections","volume":"87","author":"Fass","year":"1989","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0058|cit58","first-page":"S733","article-title":"Ticarcillin-clavulanate therapy for bacterial skin and soft tissue infections","volume":"13 Suppl 9","author":"Tan","year":"1991","journal-title":"Reviews of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/AAC.24.5.679","article-title":"Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children","volume":"24","author":"Fleisher","year":"1983","journal-title":"Antimicrobial Agents & Chemotherapy"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jac\/23.suppl_D.55","article-title":"Treatment of skin and soft tissue infections: A comparative study of cefmetazole and cefoxitin","volume":"23 Suppl D","author":"Frank","year":"1989","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"7","key":"10.1002\/14651858.CD004299.pub2-BIB0061|cit61","first-page":"1794","article-title":"Clinical evaluation of lenampicillin in the treatment of superficial suppurative skin and soft tissue infection. A double-blind study compared to amoxicillin","volume":"38","author":"Fujita","year":"1985","journal-title":"Japanese Journal of Antibiotics"},{"issue":"5A","key":"10.1002\/14651858.CD004299.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9610(88)80221-6","article-title":"A multicenter comparative study of cefotetan once daily and cefoxitin thrice daily for the treatment of infections of the skin and superficial soft tissue","volume":"155","author":"Geckler","year":"1988","journal-title":"American Journal of Surgery"},{"issue":"6C","key":"10.1002\/14651858.CD004299.pub2-BIB0063|cit63","first-page":"57S","article-title":"A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections","volume":"87","author":"Gentry","year":"1989","journal-title":"American Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD004299.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1001\/archinte.1989.00390110127028","article-title":"Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial","volume":"149","author":"Gentry","year":"1989","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004299.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00045391-199603000-00006","article-title":"Comparative effects of ceftazidime two or three times daily in patients with skin and skin structure infections","volume":"3","author":"Gentry","year":"1996","journal-title":"American Journal of Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD004299.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijantimicag.2003.07.013","article-title":"Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin\/skin structure infections: Results of a double-blind clinical trial versus piperacillin-tazobactam","volume":"23","author":"Gesser","year":"2004","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"1","key":"10.1002\/14651858.CD004299.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jinf.2003.10.001","article-title":"Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin\/skin structure infections","volume":"48","author":"Gesser","year":"2004","journal-title":"The Journal of Infection"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/AAC.27.4.648","article-title":"Once-daily ceftriaxone for skin and soft tissue infections","volume":"27","author":"Gordin","year":"1985","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD004299.pub2-BIB0069|cit69","first-page":"555","article-title":"Imipenem versus standard therapy in the treatment of serious soft tissue infection","volume":"14","author":"Gould","year":"1988","journal-title":"Drugs Under Experimental & Clinical Research"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/341026","article-title":"Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: A randomized, open-label trial","volume":"35","author":"Graham","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD004299.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00006454-199208001-00005","article-title":"Loracarbef vs. cefaclor in pediatric skin and skin structure infections","volume":"11","author":"Hanfling","year":"1992","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"2a","key":"10.1002\/14651858.CD004299.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0002-9343(85)90206-2","article-title":"Aztreonam: Worldwide overview of the treatment of patients with gram-negative infections","volume":"78","author":"Henry","year":"1985","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0073|cit73","first-page":"579","article-title":"Double-blind comparison of cephradine and cephalexin in the treatment of skin and soft-tissue infections due to Staphylococcus aureus","volume":"19","author":"Hubsher","year":"1976","journal-title":"Current Therapeutic Research, Clinical & Experimental"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01645222","article-title":"The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas","volume":"12","author":"Jorup-R\u00f6nstr\u00f6m","year":"1984","journal-title":"Infection"},{"issue":"9","key":"10.1002\/14651858.CD004299.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00006454-198909000-00008","article-title":"Randomized comparative study of ampicillin\/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children","volume":"8","author":"Kulhanjian","year":"1989","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"9","key":"10.1002\/14651858.CD004299.pub2-BIB0076|cit76","first-page":"1047","article-title":"Treatment of bacterial skin infections. An open, randomized and comparative study among roxithromycin and cephalexin","volume":"52","author":"Lobo","year":"1995","journal-title":"Revista Brasileira de Medicina"},{"issue":"3","key":"10.1002\/14651858.CD004299.pub2-BIB0077|cit77","first-page":"405","article-title":"Comparative evaluation of cefaclor versus cefadroxil in the treatment of skin and skin structure infections","volume":"46","author":"Miller","year":"1989","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0078|cit78","first-page":"56","article-title":"Safety and efficacy of cefprozil vs cefaclor in the treatment of mild to moderate skin and skin structure infections","volume":"9 Suppl C","author":"Nolen","year":"1992","journal-title":"Infections in Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0079|cit79","first-page":"613","article-title":"Ceftizoxime treatment of cutaneous and subcutaneous tissue infections","volume":"6","author":"Parish","year":"1984","journal-title":"Clinical Therapeutics"},{"issue":"6A","key":"10.1002\/14651858.CD004299.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"115S","DOI":"10.1016\/0002-9343(91)90322-O","article-title":"Systemic antimicrobial therapy in skin and skin structure infections: Comparison of temafloxacin and ciprofloxacin","volume":"91","author":"Parish","year":"1991","journal-title":"American Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004299.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-4362.1993.tb02843.x","article-title":"Clarithromycin in the treatment of skin and skin structure infections: Two multicenter clinical studies. Clarithromycin Study Group","volume":"32","author":"Parish","year":"1993","journal-title":"International Journal of Dermatology"},{"issue":"3A","key":"10.1002\/14651858.CD004299.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"166S","DOI":"10.1016\/S0002-9343(20)31159-1","article-title":"Systemic antimicrobial therapy for skin and skin structure infections: Comparison of fleroxacin and ceftazidime","volume":"94","author":"Parish","year":"1993","journal-title":"American Journal of Medicine"},{"issue":"1-2","key":"10.1002\/14651858.CD004299.pub2-BIB0083|cit83","first-page":"81","article-title":"Comparative clinical study between roxithromycin and cephalexin in the treatment of folliculitis, furunculosis and Erysipelas \/Cellulitis","volume":"53","author":"Pereira","year":"1996","journal-title":"Revista Brasileira De Medicina"},{"issue":"4A","key":"10.1002\/14651858.CD004299.pub2-BIB0084|cit84","first-page":"242","article-title":"Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections","volume":"82","author":"P\u00e9rez-Ruvalcaba","year":"1987","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1128\/AAC.24.6.856","article-title":"Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections","volume":"24","author":"Pien","year":"1983","journal-title":"Antimicrobial Agents & Chemotherapy"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/9.suppl_A.125","article-title":"Comparative effectiveness, safety and tolerance of mezlocillin and ticarcillin: A prospective randomized trial","volume":"9 Suppl A","author":"Ram\u00edrez-Ronda","year":"1982","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4A","key":"10.1002\/14651858.CD004299.pub2-BIB0087|cit87","first-page":"220","article-title":"Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections","volume":"82","author":"Ramirez-Ronda","year":"1987","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijid.2005.05.003","article-title":"Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial","volume":"9","author":"Sacchidanand","year":"2005","journal-title":"International Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004299.pub2-BIB0089|cit89","first-page":"470","article-title":"Efficacy of cefaclor AF in the treatment of skin and skin-structure infections","volume":"14","author":"Schupbach","year":"1992","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jac\/26.suppl_B.193","article-title":"Pefloxacin versus ceftazidime in therapy of soft tissue infections in compromised patients","volume":"26 Suppl B","author":"Segev","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/AAC.45.2.525-531.2001","article-title":"Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections","volume":"45","author":"Siami","year":"2001","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD004299.pub2-BIB0092|cit92","first-page":"123","article-title":"Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections","volume":"9","author":"Solomkin","year":"1986","journal-title":"Clinical Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD004299.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/AAC.44.12.3408-3413.2000","article-title":"Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections","volume":"44","author":"Stevens","year":"2000","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD004299.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1128\/AAC.37.8.1580","article-title":"Treatment of hospitalized patients with complicated skin and skin structure infections: Double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin\/Tazobactam Skin and Skin Structure Study Group","volume":"37","author":"Tan","year":"1993","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3A","key":"10.1002\/14651858.CD004299.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"159S","DOI":"10.1016\/S0002-9343(20)31158-X","article-title":"Comparative efficacy and safety of oral fleroxacin and amoxicillin\/clavulanate potassium in skin and soft tissue infections","volume":"94","author":"Tassler","year":"1993","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jac\/46.2.255","article-title":"Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections","volume":"46","author":"Wasilewski","year":"2000","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.inf.0000059403.21440.2c","article-title":"Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children","volume":"22","author":"Wible","year":"2003","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD004299.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157488608783333943","article-title":"Efficacy and safety study of fixed-dose combination of ceftriaxone-vancomycin injection in patients with various infections","volume":"3","author":"Chaudhary","year":"2008","journal-title":"Current Drug Safety"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4103\/0019-5154.57612","article-title":"Efficacy and tolerability of cefditoren pivoxil in uncomplicated skin and skin structure infections in Indian patients","volume":"54","author":"Manaktala","year":"2009","journal-title":"Indian Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/jac\/44.2.263","article-title":"Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: Two randomized, multicentre studies of quinupristin\/dalfopristin versus cefazolin, oxacillin or vancomycin","volume":"44","author":"Nichols","year":"1999","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/526527","article-title":"A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections","volume":"46","author":"Noel","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004299.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1742-1241.2008.01988.x","article-title":"The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas","volume":"63","author":"Pertel","year":"2009","journal-title":"International Journal of Clinical Practice"},{"issue":"3993","key":"10.1002\/14651858.CD004299.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.2.3993.101","article-title":"Prontosil in the treatment of erysipelas, a controlled series of 312 cases","volume":"2","author":"Snodgrass","year":"1937","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/bmj.2.4014.1156","article-title":"Sulphanilamide in the treatment of erysipelas, a controlled series of 312 case","volume":"2","author":"Snodgrass","year":"1937","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/IPC.0b013e318168fff6","article-title":"Outpatient intravenous antibiotic therapy compared with oral linezolid in patients with skin and soft tissue infections: A pharmacoeconomic analysis","volume":"16","author":"Stein","year":"2008","journal-title":"Infectious Diseases in Clinical Practice"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0106|cit106","unstructured":"The efficacy and safety evaluation of ceftriaxone and sulbactam combination (1.5 gram) in patients with skin and soft tissue infections: An open label, parallel, randomized, prospective comparative trial ISRCTN Register"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0107|cit107","unstructured":"A Multicenter, Randomized Study Comparing CUBICIN \u00ae (Daptomycin for injection) with Vancomycin in the treatment of cellulitis or erysipelas World Health Organisation International Clinical Trials Registry"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0108|cit108","unstructured":"Comparative study of ceftaroline vs. vancomycin plus aztreonam in adult subjects with complicated skin infections ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0109|cit109","unstructured":"Safety and efficacy of CEM-102 compared to linezolid in acute bacterial skin infections ClinicalTrials.gov"},{"issue":"7310","key":"10.1002\/14651858.CD004299.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/bmj.323.7310.446","article-title":"Concealing treatment allocation in randomised trials","volume":"323","author":"Altman","year":"2001","journal-title":"British Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD004299.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0161-6420(00)00178-0","article-title":"Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination","volume":"107","author":"Ambati","year":"2000","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD004299.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1984.03340320035023","article-title":"Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs","volume":"251","author":"Baddour","year":"1984","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/archderm.1987.01660280070025","article-title":"Early detection of streptococcal group antigens in skin samples by latex particle agglutination","volume":"123","author":"Bernard","year":"1987","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0114|cit114","unstructured":"British Lymphology Society Consensus Document on the Management of Cellulitis in Lymphoedema www.lymphoedema.org\/lsn\/"},{"issue":"7","key":"10.1002\/14651858.CD004299.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archsurg.1995.01430070108024","article-title":"Clinical features and aerobic and anaerobic microbiological characteristics of cellulitis","volume":"130","author":"Brook","year":"1995","journal-title":"Archives of Surgery (Chicago, Ill. : 1960)"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.12968\/bjon.2007.16.Sup1.27089","article-title":"Cellulitis and treatment: A qualitative study of experiences","volume":"16","author":"Carter","year":"2007","journal-title":"British Journal of Nursing"},{"issue":"6991","key":"10.1002\/14651858.CD004299.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.310.6991.1360","article-title":"Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: Open, randomised controlled trial","volume":"310","author":"Chan","year":"1995","journal-title":"BMJ"},{"issue":"7483","key":"10.1002\/14651858.CD004299.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/bmj.38309.447975.EB","article-title":"Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital","volume":"330","author":"Corwin","year":"2005","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD004299.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/014107689809101206","article-title":"Management and morbidity of cellulitis of the leg","volume":"91","author":"Cox","year":"1998","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1365-2133.2006.07419.x","article-title":"Oedema as a risk factor for multiple episodes of cellulitis\/erysipelas of the lower leg: A series with community follow-up","volume":"155","author":"Cox","year":"2006","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0121|cit121","unstructured":"Clinical Resource Efficiency Support Team (CREST) Guidelines on the management of cellulitis in adults http\/\/www.crestni.org.uk 2005"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0122|cit122","first-page":"105","article-title":"Complications of varicose vein surgery","volume":"79","author":"Critchley","year":"1997","journal-title":"Annals of the Royal College of Surgeons of England"},{"issue":"7198","key":"10.1002\/14651858.CD004299.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.318.7198.1591","article-title":"Risk factors for erysipelas of the leg (cellulitis): Case-control study","volume":"318","author":"Dupuy","year":"1999","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1017\/S095026880500484X","article-title":"Cellulitis incidence in a defined population","volume":"134","author":"Ellis Simonsen","year":"2006","journal-title":"Epidemiology and Infection"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/clinids\/23.5.1091","article-title":"Erysipelas: Clinical and bacteriologic spectrum and serological aspects","volume":"23","author":"Eriksson","year":"1996","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkg466","article-title":"Managing skin and soft tissue infections: Expert panel recommendations on key decision points","volume":"52 Suppl 1","author":"Eron","year":"2003","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD004299.pub2-BIB0127|cit127","first-page":"1844","article-title":"Risk factors for early wound complications after orthopedic surgery for rheumatoid arthritis","volume":"22","author":"Escalante","year":"1995","journal-title":"The Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1532-5415.1997.tb01468.x","article-title":"The impact of ageing and chronic disease on use of hospital and outpatient services in a large HMO: 1971-1991","volume":"45","author":"Haan","year":"1997","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0129|cit129","first-page":"27.16","volume-title":"Rook's Textbook of Dermatology","volume":"1","author":"Hay","year":"2004"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0130|cit130","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.104.1.79","article-title":"Oral versus initial intravenous therapy for urinary tract infections in young febrile children","volume":"104","author":"Hoberman","year":"1999","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01650206","article-title":"Recurrent erysipelas: Predisposing factors and costs of prophylaxis","volume":"15","author":"Jorup-R\u00f6nstr\u00f6m","year":"1987","journal-title":"Infection"},{"issue":"7303","key":"10.1002\/14651858.CD004299.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD004299.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1056\/NEJM199907293410502","article-title":"Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy","volume":"341","author":"Kern","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1469-0691.2006.01341.x","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: Current perspectives","volume":"12 Suppl 1","author":"Kluytmans-Vandenbergh","year":"2006","journal-title":"Clinical Microbiology and Infection"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0002-9378(97)70342-9","article-title":"The effect of placental removal method on the incidence of postcesarean infections","volume":"176","author":"Lasley","year":"1997","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000090649","article-title":"Risk factors for erysipelas of the leg in Tunisia: A multicenter case-control study","volume":"212","author":"Mokni","year":"2006","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0138|cit138","first-page":"1146","volume-title":"Clinical Evidence","author":"Morris","year":"2001"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0139|cit139","unstructured":"Randomised controlled trials to investigate whether prophylactic antibiotics can prevent further episodes of cellulitis (erysipelas) of the leg clinicaltrials.gov"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1439-0353.2004.03028.x","article-title":"Recurrent erysipelas: Risk factors","volume":"2","author":"Pavlotsky","year":"2004","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft"},{"issue":"10","key":"10.1002\/14651858.CD004299.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/archpedi.159.10.980","article-title":"Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: A 14-year study at Driscoll Children's Hospital","volume":"159","author":"Purcell","year":"2005","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0142|cit142","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004979.pub2","article-title":"Oral antibiotics versus parenteral antibiotics for severe pneumonia in children","author":"Rojas","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004299.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000080853","article-title":"Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: A case-control study","volume":"209","author":"Roujeau","year":"2004","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0144|cit144","volume-title":"British National Formulary","author":"Royal Pharmaceutical Society of Great Britain","year":"2007"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0145|cit145","first-page":"463","article-title":"Erysipelas and necrotizing fasciitis","volume":"128","year":"2001","journal-title":"Annales de dermatologie et de v\u00e9n\u00e9r\u00e9ologie"},{"issue":"6","key":"10.1002\/14651858.CD004299.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1365-2133.2007.08423.x","article-title":"Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis","volume":"158","author":"Soo J","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD004299.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/497143","article-title":"Practice guidelines for the diagnosis and management of skin and soft-tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004299.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1358836X9900400205","article-title":"An analysis of limb-threatening lower extremity wound complications after 1090 consecutive coronary artery bypass procedures","volume":"4","author":"Thomas","year":"1999","journal-title":"Vascular medicine (London, England)"},{"key":"10.1002\/14651858.CD004299.pub2-BIB0149|cit149","unstructured":"United Kingdom Department of Health Hospital Episode Statistics 2001 www.statistics.gov.uk"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004299.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T14:35:10Z","timestamp":1703687710000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004299.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,6,16]]},"references-count":149,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004299.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,16]]}}}